The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Taranenko A.V.

Patologoanatomicheskoe otdelenie GBUZ "Oblastnoĭ onkologicheskiĭ dispanser", Irkutsk

Dvornichenko V.V.

Patologoanatomicheskoe otdelenie GBUZ "Oblastnoĭ onkologicheskiĭ dispanser", Irkutsk;
GBOU dopolnitel'nogo professional'nogo obucheniia "Irkutskaia gosudarstvennaia meditsinskaia akademiia poslediplomnogo obrazovaniia"

Batoroev Iu.K.

GBOU dopolnitel'nogo professional'nogo obucheniia "Irkutskaia gosudarstvennaia meditsinskaia akademiia poslediplomnogo obrazovaniia"

Results of karyometry of acinar adenocarcinoma of the prostate

Authors:

Taranenko A.V., Dvornichenko V.V., Batoroev Iu.K.

More about the authors

Read: 1059 times


To cite this article:

Taranenko AV, Dvornichenko VV, Batoroev IuK. Results of karyometry of acinar adenocarcinoma of the prostate. Russian Journal of Archive of Pathology. 2012;74(5):41‑43. (In Russ.)

Recommended articles:
Patterns of CAF expression in tumors of the geni­tourinary system. Russian Journal of Archive of Pathology. 2024;(6):28-35
The phenomenon of tumor budding in gastric cancer. Russian Journal of Archive of Pathology. 2025;(2):79-87
Difficult intu­bation risk asse­ssment in bariatric surgery. Russian Journal of Anesthesiology and Reanimatology. 2025;(1):62-68
Rela­tionship between stroke-associated pneumonia and long-term outcomes of ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):57-61
Diagnosis and treatment of ovarian cancer in pregnancy. Russian Bulletin of Obstetrician-Gynecologist. 2025;(3):27-33

References:

  1. Kogan M.I., Loran O.B., Petrov S.B. Radikal'naya khirurgiya raka predstatel'noi zhelezy. M.: GEOTAR-Media; 2006.
  2. Lang T.A., Sesik M. Kak opisyvat' statistiku v meditsine. Annotirovannoe rukovodstvo dlya avtorov, redaktorov i retsenzentov: Per. s angl. M.: Prakticheskaya meditsina; 2011: 32.
  3. Mamaev A.N. Osnovy meditsinskoi statistiki. M.: Prakticheskaya meditsina; 2011.
  4. Aragona F., Franco V., Rodolico V., Dardanoni G., Cabibi D., Melloni D. et al. Interactive computerized morphometric analysis for the differential diagnosis between dysplasia and well differentiated adenocarcinoma of the prostate. Urol. Res. 1989; 17: 35-40.
  5. Buhmeida A., Kuopio T., Collan Y. Nuclear size and shape in fine needle aspiration biopsy samples of the prostate. Anal. Quant. Cytol. Histol. 2000; 22 (4): 291-8.
  6. Buhmeida A., Pyrhönen S., Laato M., Collan Y. Prognostic factors in prostate cancer. Diagn Pathol. 2006; 1: 4.
  7. Cintra M., Billis A. Histologic grading of prostatic adenocarcinoma: intraobserver reproducibility of the Mostofi, Gleason and Böcking grading systems. Int. Urol. Nephrol. 1991; 23 (5): 449-54.
  8. Diamond D.A., Berry S.J., Umbricht C., Jewett H.J., Coffey D.S. Computerized image analysis of nuclear shape as a prognostic factor for prostatic cancer. Prostate. 1982; 3 (4): 321-32.
  9. Diamond D.A., Berry S.J., Jewett H.J., Eggleston J.C., Coffey D.S. A new method to assess metastatic potential of human prostate cancer: relative nuclear roundness. J. Urol. 1982; 128: 729-34.
  10. Eichenberger T., Mihatsch M.J., Oberholzer M., Gschwind R., Rutishauser G. Are nuclear shape factors good predictors of the disease course in patients with carcinoma of the prostate. Prog. Clin. Biol. Res. 1987; 243A: 533-7.
  11. Maffini M.V., Ortega H.H., Stoker C., Giardina R.H., Luque E.H., Munoz de Toro M.M. Bcl-2 correlates with tumor ploidy and nuclear morphology in early stage prostate carcinoma. Pathol. Res. Pract. 2001; 197 (7): 487-92.
  12. Martínez-Jabaloyas J.M., Ruiz-Cerdá J.L., Hernández M., Jiménez A., Jiménez-Cruz F. Prognostic value of DNA ploidy and nuclear morphometry in prostate cancer treated with androgen deprivation. Urology. 2002; 59 (5): 715-20.
  13. Myers R.P., Neves R.J., Farrow G.M., Utz D.C. Nucleolar grading of prostatic adenocarcinoma: light microscopic correlation with disease progression. Prostate. 1982; 3 (5): 423-32.
  14. Partin A.W., Walsh A.C., Pitcock R.V., Mohler J.L., Epstein J.I., Coffey D.S. A comparison of nuclear morphometry and Gleason grade as a predictor of prognosis in stage A2 prostate cancer: a critical analysis. J. Urol. 1989; 142: 1254-8.
  15. Partin A.W., Steinberg G.D., Pitcock R.V., Wu L., Piantadosi S., Coffey D.S., Epstein J.I. Use of nuclear morphometry, Gleason histologic scoring, clinical stage, and age to predict disease-free survival among patients with prostate cancer. Cancer. 1992; 70: 161-8.
  16. Tannenbaum M., Tannenbaum S., deSanctis P.N., Olsson C.A. Prognostic significance of nucleolar surface area in prostate cancer. Urology. 1982; 19 (5): 546-51.
  17. Vesalainen S., Lipponen P., Talja M., Kasurinen J., Syrjänen K. Nuclear morphometry is of independent prognostic value only in T1 prostatic adenocarcinomas. Prostate. 1995; 27: 110-7.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.